Roche Inks Another AAV Capsid Platform Technology Deal, With Avista Therapeutics

 
• By Alaric DeArment
Avista and Roche signed a deal to use Avista's capsid technology in developing gene therapies for eye diseases • Source: Shutterstock

More from Deals

More from Business